跳至主要内容
临床试验/CTRI/2024/01/061763
CTRI/2024/01/061763招募中3 期

A prospective, interventional, open-label clinical study to evaluate thesafety and efficacy of Febrojith Tablet in the management of pyrexia,immunomodulatory, anti inflammatory effects - NI

The Arya Vaidya Pharmacy Coimbatore Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age between 2 to 60 years both male and female.
  • 2.Subject diagnosed with fever (moderate to high grade).
  • 3.Subjects willing and able to provide informed consent voluntarily.
  • 4.Patient is willing and able to comply with all trial requirements.

排除标准

  • 1.Pregnant or Breast feeding.
  • 2.Inability to provide voluntary consent.
  • 3.Volunteers who have participated in any drug research study within past 3 months
  • 4.Evidence of significant uncontrolled comorbid disease which in the investigators opinion would jeopardize patient participation.
  • 5.Any clinically significant medical history medical finding or an ongoing medical or psychiatric condition exists which in the opinion of the Investigator could jeopardize the safety of the subject impact validity of the study results or interfere with the completion of study according to the protocol.
  • 6.History of cancer including solid tumors hematologic malignancies and carcinoma in situ.
  • 7.Use of any anti psychotic drugs in the past.
  • 8.Subjects who abuse drugs or alcohol drug screening not required.
  • 9.Use of any investigational medication within 4 weeks prior to start of study drug.

研究者

发起方
The Arya Vaidya Pharmacy Coimbatore Ltd

相似试验